http://www.nytimes.com/2015/03/16/busin ... =RecEngine
Among the problems:
Executives at CVS Health, a leading pharmacy benefits manager, recently said that PCSK9 inhibitors might cost $7,000 to $12,000 a year and would strain health care budgets because so many people might use them.
While the drugs appeared generally safe, there was evidence that they could cause memory problems.
